Drugs / DR-0202
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06999187 | Jun 2025 → Jul 2027 expected | castration-resistant prostate carcinoma, cervical cancer, endometrial cancer, gastric cancer +7 | Dren Bio | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DR-0202 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06999187 ↗ |